Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monoclonal Gammopathy-Associated Neuropathy.
Sarosiek S, Doughty CT, Castillo JJ. Sarosiek S, et al. Curr Hematol Malig Rep. 2024 Dec 16;20(1):2. doi: 10.1007/s11899-024-00745-8. Curr Hematol Malig Rep. 2024. PMID: 39680359 Review.
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells.
Munshi M, Liu X, Kofides A, Tsakmaklis N, Hunter ZR, Guerrera ML, Canning A, Gustine JN, Liu S, Hatcher JM, Chen J, Meid K, Sarosiek S, Flynn CA, Branagan AR, von Keudell G, Palomba LM, Castillo JJ, Yang G, Treon SP. Munshi M, et al. Among authors: sarosiek s. Br J Haematol. 2024 Nov;205(5):1866-1872. doi: 10.1111/bjh.19756. Epub 2024 Sep 18. Br J Haematol. 2024. PMID: 39295138
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical Problems.
Bibas M, Sarosiek S, Castillo JJ. Bibas M, et al. Among authors: sarosiek s. Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024061. doi: 10.4084/MJHID.2024.061. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38984103 Free PMC article. Review.
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia.
Zanwar S, Le-Rademacher J, Durot E, D'Sa S, Abeykoon JP, Mondello P, Kumar S, Sarosiek S, Paludo J, Chhabra S, Cook JM, Parrondo R, Dispenzieri A, Gonsalves WI, Muchtar E, Ailawadhi S, Kyle RA, Rajkumar SV, Delmer A, Fonseca R, Gertz MA, Treon SP, Ansell SM, Castillo JJ, Kapoor P. Zanwar S, et al. Among authors: sarosiek s. J Clin Oncol. 2024 Jul 20;42(21):2527-2536. doi: 10.1200/JCO.23.02066. Epub 2024 May 24. J Clin Oncol. 2024. PMID: 38788183 Free PMC article.
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia.
Richardson K, Castillo JJ, Sarosiek SR, Branagan AR, Flynn CA, Meid K, Gustine JN, Liu X, Kofides A, Liu S, Wolf JL, Kacena KA, Patterson CJ, Guerrera ML, Tsakmaklis N, Treon SP, Hunter ZR. Richardson K, et al. Among authors: sarosiek sr. Blood Adv. 2024 May 14;8(9):2133-2137. doi: 10.1182/bloodadvances.2023012111. Blood Adv. 2024. PMID: 38237078 Free PMC article. No abstract available.
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia.
Castillo JJ, Branagan AR, Sermer D, Flynn CA, Meid K, Little M, Stockman K, White T, Canning A, Guerrera ML, Kofides A, Liu S, Liu X, Richardson K, Tsakmaklis N, Patterson CJ, Hunter ZR, Treon SP, Sarosiek S. Castillo JJ, et al. Among authors: sarosiek s. Blood. 2024 Feb 15;143(7):582-591. doi: 10.1182/blood.2023022420. Blood. 2024. PMID: 37971194 Free PMC article.
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition.
Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR, Castillo JJ, Sarosiek S, Flynn C, LeBoeuf NR. Leung BW, et al. Among authors: sarosiek s. Leuk Lymphoma. 2023 Dec;64(12):2047-2050. doi: 10.1080/10428194.2023.2245091. Epub 2023 Sep 6. Leuk Lymphoma. 2023. PMID: 37671695 No abstract available.
81 results